Incyte Reports 2018 First-Quarter Financial Results and Updates on Key Clinical Programs
Go back to Incyte Reports 2018 First-Quarter Financial Results and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 115.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.62 | 52 Week High | $118.49 | |||
| Open | $115.62 | 52 Week Low | $55.00 | |||
| Day High | $115.62 | P/E | N/A | |||
| Day Low | $115.62 | EPS | $-0.56 | |||
| Volume | 1,836 | |||||
